Pure Global

BD OneFlow 漿細胞檢驗試劑 - Taiwan Registration d268726a854717fc4290160c3ef09c0d

Access comprehensive regulatory information for BD OneFlow 漿細胞檢驗試劑 in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number d268726a854717fc4290160c3ef09c0d and manufactured by Becton, Dickinson and Company, BD Biosciences;; Becton, Dickinson Caribe, Ltd.. The authorized representative in Taiwan is BECTON DICKINSON HOLDINGS PTE. LTD. TAIWAN BRANCH (SINGAPORE).

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
d268726a854717fc4290160c3ef09c0d
Registration Details
Taiwan FDA Registration: d268726a854717fc4290160c3ef09c0d
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

BD OneFlow 漿細胞檢驗試劑
Risk Class 2

Registration Details

d268726a854717fc4290160c3ef09c0d

DHA05603707906

Product Details

The OneFlow Plasma Cell Disease Test is used as a diagnostic aid to differentiate between patients with hematologic abnormalities and suspected plasma cell disorders. The OneFlow Plasma Cell Disease Test can be used with collected EDTA or bone marrow specimens from heparin tubes. Results must be interpreted by a pathologist or equivalent professional in conjunction with other clinical or laboratory findings.

B Hematology, pathology, and genetics

B.5220 Automatic Differentiation Cell Counter

QMS/QSD;; 輸入

Dates and Status

May 23, 2024

May 23, 2029